Tsao S C, Sugiyama Y, Sawada Y, Nagase S, Iga T, Hanano M
J Pharmacokinet Biopharm. 1986 Feb;14(1):51-64. doi: 10.1007/BF01059283.
Multiple indicator dilution studies of warfarin uptake were carried out on isolated perfused rat livers in the presence and absence of bovine serum albumin (BSA) in the perfusate using normal rats and Nagase analbuminemic rats (NAR). A distributed model was fitted to the dilution data and estimates of influx, efflux, and sequestration rate constants were obtained. In both groups of rats, the intrinsic clearance for unidirectional hepatic uptake (CLint,influx) of warfarin in the presence of 1.6 g/dl BSA was approximately 37-45% of that in the absence of BSA, while the unbound fraction of warfarin with 1.6 g/dl BSA in the perfusate was only 4.2% of that in the absence of BSA. Thus the degree of BSA-induced reduction of the value of CLint,influx and that of the unbound fraction are different. From these observations, it was found that the hepatic uptake of warfarin is not driven solely by the unbound concentration of warfarin, supporting the recent concepts of albumin-mediated transport for tightly albumin bound ligands as reported by Ockner et al. In addition, the fact that the same hepatic uptake mechanism of warfarin was also observed in NAR suggested that the hepatic uptake of warfarin may not necessarily require a special albumin receptor on the hepatocyte surface.
在有和没有灌注液中牛血清白蛋白(BSA)存在的情况下,使用正常大鼠和长谷无白蛋白血症大鼠(NAR),对分离的灌注大鼠肝脏进行了华法林摄取的多指标稀释研究。将一个分布模型拟合到稀释数据上,并获得了流入、流出和滞留速率常数的估计值。在两组大鼠中,在存在1.6g/dl BSA的情况下,华法林单向肝摄取的内在清除率(CLint,influx)约为不存在BSA时的37 - 45%,而灌注液中含有1.6g/dl BSA时华法林的未结合分数仅为不存在BSA时的4.2%。因此,BSA诱导的CLint,influx值降低程度和未结合分数降低程度是不同的。从这些观察结果发现,华法林的肝摄取并非仅由华法林的未结合浓度驱动,这支持了Ockner等人报道的白蛋白介导紧密结合白蛋白配体转运的最新概念。此外,在NAR中也观察到相同的华法林肝摄取机制这一事实表明,华法林的肝摄取不一定需要肝细胞表面有特殊的白蛋白受体。